Beneficial ownership — 13D / 13G
87,240 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| Saba Capital Management, L.P. | CEV Eaton Vance California Municipal Income Trust | 13D/A | 13.68% | Dec 13, 2023 | 2y |
| PAR Investment Partners, L.P. | GRPN Groupon, Inc. | 13G/A | 2.7% | Dec 13, 2023 | 2y |
| Volition Capital Fund IV, L.P. | GROV Grove Collaborative Holdings, Inc. | 13D/A | 16.8% | Dec 13, 2023 | 2y |
| Magnetar Financial LLC | CMTL Comtech Telecommunications Corp | 13D/A | 11.73% | Dec 13, 2023 | 2y |
| Robert W. Duggan | PLSE Pulse Biosciences, Inc. | 13D/A | 68.8% | Dec 12, 2023 | 2y |
| Orin Hirschman | INAB In8bio, Inc. | 13G | 9.4% | Dec 11, 2023 | 2y |
| NOVO HOLDINGS A/S | LXEO Lexeo Therapeutics, Inc. | 13G/A | 4.9% | Dec 11, 2023 | 2y |
| L1 Capital Global Opportunities Master Fund, Ltd. | PHUN Phunware, Inc. | 13G | 9.32% | Dec 9, 2023 | 2y |
| ARCH Venture Fund XII, L.P. | NMRA Neumora Therapeutics, Inc. | 13D/A | 20.9% | Dec 8, 2023 | 2y |
| Equinox Partners Investment Management LLC | GAU Galiano Gold Inc. | 13G/A | 15.8% | Dec 8, 2023 | 2y |
| Fourth Sail Capital LP | ARCE Arco Platform Limited Class A Common Shares | 13G/A | 0% | Dec 7, 2023 | 2y |
| JUPITER ASSET MANAGEMENT LTD | WU Western Union CO | 13G | 4.96% | Dec 6, 2023 | 2y |
| Aimei Investment Ltd | AFJK Aimei Health Technology Co., Ltd. | 13D | 21.1% | Dec 6, 2023 | 2y |
| Atalaya Capital Management LP | AAGR African Agriculture Holdings Inc. Common Stock | 13G/A | 9.69% | Dec 6, 2023 | 2y |
| Antofagasta plc | BVN Buenaventura Mining Co Inc | 13D | 18.9% | Dec 5, 2023 | 2y |
| Amster Howard | WHLR Wheeler Real Estate Investment Trust, Inc. | 13D | 7.87% | Dec 5, 2023 | 2y |
| Li Kin Shing | FEBO Fenbo Holdings Ltd | 13D | 72.73% | Dec 1, 2023 | 2y |
| Genextra S.p.A. | IRLA IRulya Therapeutics Inc. | 13G | 5.89% | Oct 20, 2023 | 2y |
| Ganz Bryan | BYRN Byrna Technologies Inc. | 13D | 7.7% | May 27, 2022 | 2y |
| Caligan Partners LP | LQDA Liquidia Corp | 13D/A | 15.1% | Dec 14, 2023 | 2y |
| Centerbridge Credit Partners Master, L.P. | GTX Garrett Motion Inc. | 13D/A | 16.42% | Dec 13, 2023 | 2y |
| Saba Capital Management, L.P. | NXJ NUVEEN NEW JERSEY QUALITY MUNICIPAL INCOME FUND | 13D/A | 13.4% | Dec 12, 2023 | 2y |
| Athanor Capital, LP | ZURA Zura Bio Ltd | 13G | 11.01% | Dec 12, 2023 | 2y |
| MMCAP International Inc. SPC | WSTRF Western Uranium & Vanadium Corp. | 13G | 9.99% | Dec 12, 2023 | 2y |
| L. John Doerr | AMRS Amyris Inc. | 13D/A | 31.2% | Dec 12, 2023 | 2y |
| Saba Capital Management, L.P. | SABA Saba Capital Income & Opportunities Fund II | 13D/A | 17.28% | Dec 12, 2023 | 2y |
| James N. Topper | KALV KalVista Pharmaceuticals, Inc. | 13D/A | 10.4% | Dec 12, 2023 | 2y |
| Walmart Inc. | SYM Symbotic Inc. | 13D/A | 52.6% | Dec 12, 2023 | 2y |
| Abdiel Qualified Master Fund, LP | APPN Appian Corp | 13D/A | 15.8% | Dec 12, 2023 | 2y |
| MAK CAPITAL ONE LLC | AGYS Agilysys Inc | 13D/A | 14% | Dec 11, 2023 | 2y |
| Cowen Financial Products LLC | CNGL Canna-Global Acquisition Corp. Class A Common Stock | 13G | 10.1% | Dec 7, 2023 | 2y |
| Cormorant Asset Management, LP | EYPT EyePoint, Inc. | 13G/A | 12.36% | Dec 4, 2023 | 2y |
| George Economou | SHIP Seanergy Maritime Holdings Corp. | 13D/A | 7.2% | Dec 13, 2023 | 2y |
| Liang Meng | HOLI Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island) | 13D/A | 13.7% | Dec 11, 2023 | 2y |
| Robert Davidow | ATXI Avenue Therapeutics, Inc. | 13G/A | 9.89% | Dec 11, 2023 | 2y |
| Engine Capital, L.P. | OFIX Orthofix Medical Inc. | 13D/A | 8.3% | Dec 11, 2023 | 2y |
| ORBIMED ADVISORS LLC | KROS Keros Therapeutics, Inc. | 13D/A | 4.2% | Dec 11, 2023 | 2y |
| Saba Capital Management, L.P. | BMEZ BlackRock Health Sciences Term Trust | 13D/A | 14.63% | Dec 11, 2023 | 2y |
| Firment Shipping Inc. | GLBS Globus Maritime Ltd | 13D/A | 20.5% | Dec 11, 2023 | 2y |
| Karpus Management, Inc. | WIA Western Asset Inflation-Linked Income Fund | 13D | 30.47% | Dec 11, 2023 | 2y |
| Silver Point Capital L.P. | GPOR Gulfport Energy Corp | 13D/A | 36.9% | Dec 11, 2023 | 2y |
| Saba Capital Management, L.P. | BCAT BlackRock Capital Allocation Term Trust | 13D/A | 12.42% | Dec 11, 2023 | 2y |
| Ara K. Hovnanian | HOV Hovnanian Enterprises Inc | 13D/A | 15.1% | Dec 11, 2023 | 2y |
| RA CAPITAL MANAGEMENT, L.P. | ETNB 89bio, Inc. Common Stock | 13D/A | 13.6% | Dec 11, 2023 | 2y |
| Engaged Capital LLC | UPBD Upbound Group, Inc. | 13D/A | 4.7% | Dec 11, 2023 | 2y |
| BAKER BROS. ADVISORS LP | PRLD Prelude Therapeutics Inc | 13D/A | 24.3% | Dec 11, 2023 | 2y |
| Western Standard LLC | MACK Merrimack Pharmaceuticals, Inc. | 13D/A | 15.5% | Dec 7, 2023 | 2y |
| Keenan Capital, LLC | ARCE Arco Platform Limited Class A Common Shares | 13D/A | 0% | Dec 7, 2023 | 2y |
| GARDNER LEWIS ASSET MANAGEMENT L P | BSQR BSQUARE Corporation | 13D/A | 0% | Dec 7, 2023 | 2y |
| Fred B. Craves | MDGL Madrigal Pharmaceuticals, Inc. | 13D/A | 2.9% | Dec 7, 2023 | 2y |